These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20830766)

  • 1. Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol.
    Albert M; Kiefer MV; Sun W; Haller D; Fraker DL; Tuite CM; Stavropoulos SW; Mondschein JI; Soulen MC
    Cancer; 2011 Jan; 117(2):343-52. PubMed ID: 20830766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
    Kiefer MV; Albert M; McNally M; Robertson M; Sun W; Fraker D; Olthoff K; Christians K; Pappas S; Rilling W; Soulen MC
    Cancer; 2011 Apr; 117(7):1498-505. PubMed ID: 21425151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
    Leichman CG; Jacobson JR; Modiano M; Daniels JR; Zalupski MM; Doroshow JH; Fletcher WS; Macdonald JS
    Cancer; 1999 Sep; 86(5):775-81. PubMed ID: 10463975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization.
    Rajan DK; Soulen MC; Clark TW; Baum RA; Haskal ZJ; Shlansky-Goldberg RD; Freiman DB
    J Vasc Interv Radiol; 2001 Feb; 12(2):187-93. PubMed ID: 11265882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population.
    Solomon B; Soulen MC; Baum RA; Haskal ZJ; Shlansky-Goldberg RD; Cope C
    J Vasc Interv Radiol; 1999 Jun; 10(6):793-8. PubMed ID: 10392950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.
    Mouli SK; Hickey R; Thornburg B; Sato KT; Desai K; Gabr A; Kallini JR; Niemeri H; Kircher S; Mulcahy MF; Benson Iii AB; Gupta R; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2016 Sep; 27(9):1279-1287. PubMed ID: 27062355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
    Makary MS; Kapke J; Yildiz V; Pan X; Dowell JD
    J Vasc Interv Radiol; 2016 Sep; 27(9):1298-1304. PubMed ID: 27499157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.
    Koizumi Y; Hirooka M; Uehara T; Kisaka Y; Uesugi K; Kumagi T; Abe M; Matsuura B; Hiasa Y; Onji M
    Hepatogastroenterology; 2011; 58(106):512-5. PubMed ID: 21661422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hazardous chemical splatter during liver chemoembolization.
    Gaba RC
    J Vasc Interv Radiol; 2010 Nov; 21(11):1663-4, 1664.e1. PubMed ID: 20884232
    [No Abstract]   [Full Text] [Related]  

  • 12. [Home therapy approach in cancer patients-chemotherapy (case 2-3)--intra-arterial infusion cancer chemotherapy for hepatic metastasis of colorectal cancer--case report].
    Shinohara K; Miura T
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():558-60; discussion 560-3. PubMed ID: 7802465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization for liver metastases from colorectal carcinoma: risk or a benefit.
    Popov I; Lavrnić S; Jelić S; Jezdić S; Jasović A
    Neoplasma; 2002; 49(1):43-8. PubMed ID: 12044059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
    Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
    Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined hepatic-artery and portal-vein chemoembolization for colorectal cancer metastatic to the liver].
    Tarazov PG; Granov DA; Polikarpov AA; Polisalov VN; Borovik VV
    Vopr Onkol; 2002; 48(1):83-7. PubMed ID: 12101575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.
    Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T
    Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of liver metastases from colorectal cancer.
    Isenberg J; Fischbach R; Krüger I; Keller HW
    Anticancer Res; 1996; 16(3A):1291-5. PubMed ID: 8702252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
    Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.